Polycystic kidney disease
MONDO:0020642A usually autosomal dominant and less frequently autosomal recessive genetic disorder characterized by the presence of numerous cysts in the kidneys leading to end-stage renal failure. The autosomal dominant trait is associated with abnormalities on the short arm of chromosome 16. Symptoms in patients with the autosomal dominant trait usually appear at middle age and include abdominal pain, hematuria, and high blood pressure. Patients may develop brain aneurysms and liver cysts. Patients with the autosomal recessive trait present with progressive renal failure early in life and symptoms resulting from hepatic fibrosis. The autosomal recessive trait is associated with abnormalities of chromosome 6. Polycystic kidney disease may also result as a side effect in patients on renal dialysis.
Also known as: PKD - polycystic kidney disease, fibrocystic renal disease, polycystic kidney disease
66 clinical trials for this condition and its sub-types, 13 tagged with Polycystic kidney disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Polycystic kidney disease
-
7 sub-types
- Polycystic kidney disease 1 1 trial
- ALG9-associated autosomal dominant polycystic kidney disease 0 trials
- Polycystic kidney disease 2 0 trials
- Polycystic kidney disease 3 with or without polycystic liver disease 0 trials
- Polycystic kidney disease 6 with or without polycystic liver disease 0 trials
- Polycystic kidney disease 7 0 trials
- Polycystic kidney disease 8 0 trials
-
2 sub-types
- Polycystic kidney disease 4 0 trials
- Polycystic kidney disease 5 0 trials
-
Can a ketone drink shield kidneys?
Disease control CompletedResearchers are testing whether a ketone supplement drink can reduce protein in the urine and improve kidney function in people with chronic kidney disease or polycystic kidney disease. The study includes 45 participants who receive either the ketone drink or a placebo for four w…
Sponsor: Gødstrup Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug PB shows promise for slowing excessive urination in kidney patients
Symptom relief CompletedThis study tested whether the medication PB can safely reduce excessive urination in people with certain kidney diseases, including inherited nephrogenic diabetes insipidus, lithium-induced diabetes insipidus, and polycystic kidney disease treated with tolvaptan. Researchers meas…
Phase 2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New study reveals IVF success for kidney disease carriers
Knowledge-focused CompletedThis study looked at 44 couples where one or both partners have polycystic kidney disease (PKD). They used IVF combined with genetic testing to select embryos without the disease. The goal was to see how often these treatments led to a healthy pregnancy and live birth, and to tra…
Sponsor: Azienda Sanitaria Universitaria Integrata del Trentino • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC